The University of Missouri-Columbia (MU) is applying for a P-20 Pre-In vivo Cellular and Molecular Imaging (PRE-ICMIC) planning grant. The research projects that will be supported by this grant focus on the identification and development of single photon emitting site-directed in vivo targeting biomolecule- conjugates directed to cell surface receptor antigens and angiogenesis markers with high specificity. Molecular biological techniques form the primary approach for the design and generation of new cancer targeting vectors (incl., phage display, combinatorial chemistry and SPPS). The PRE-ICMIC will provide essential support to catalyze the formation of interdisciplinary research teams which are composed of scientists that combine expertise in molecular biology, chemistry, radiopharmaceutical chemistry, comparative oncology, pharmacology, tumor biology and pathology, and Nuclear Medicine. The research programs developed as part of this PRE-ICMIC are focussed on development of Tc-99m- and In-111-labeled diagnostic imaging agents. The organizational structure and Core facilities that will be instituted will support and promote cross-disciplinary research activities. This planning grant will be a critical milestone for establishment of a ICMIC at MU and will facilitate expansion and enhance the scope and quality of the radiopharmaceutical sciences research related to development of novel, highly specific cancer targeting imaging agents at this institution. At the completion of this grant, MU plans to be positioned to successfully apply for a P-50 ICMIC.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (J2))
Program Officer
Menkens, Anne E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Missouri-Columbia
Schools of Medicine
United States
Zip Code
Glinskii, Olga V; Turk, James R; Pienta, Kenneth J et al. (2004) Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells. J Physiol 554:89-99
Smith, C Jeffrey; Gali, Hariprasad; Sieckman, Gary L et al. (2003) Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl Med Biol 30:101-9
Khaldoyanidi, Sophia K; Glinsky, Vladislar V; Sikora, Lyudmila et al. (2003) MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem 278:4127-34
Smith, C Jeffrey; Gali, Hariprasad; Sieckman, Gary L et al. (2003) Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties. Bioconjug Chem 14:93-102
Gallazzi, Fabio; Wang, Yi; Jia, Fang et al. (2003) Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene. Bioconjug Chem 14:1083-95
Glinsky, Vladislav V; Glinsky, Gennadi V; Glinskii, Olga V et al. (2003) Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 63:3805-11
Glinskii, Olga V; Huxley, Virginia H; Turk, James R et al. (2003) Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endothelium. Clin Exp Metastasis 20:451-8
Lewis, Michael R; Jia, Fang; Gallazzi, Fabio et al. (2002) Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: preparation, characterization, and in vitro mRNA binding. Bioconjug Chem 13:1176-80